IM Cannabis Q2 EPS $(0.19) Misses $(0.07) Estimate, Sales $9.83M Miss $13.44M Estimate
Portfolio Pulse from Benzinga Newsdesk
IM Cannabis reported Q2 earnings per share from continuing operations of $0.19, missing the estimate of $0.20. The company's sales were $9.83 million, falling short of the estimated $13.20 million.
August 14, 2023 | 12:03 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
IM Cannabis reported lower than expected Q2 earnings and sales, which could negatively impact the company's stock price in the short term.
Earnings reports are a significant factor in a company's stock price. IM Cannabis reported lower than expected earnings and sales for Q2, which could lead to a decrease in the company's stock price as it indicates potential financial instability or underperformance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100